Gland Pharma (GLAND.NS) Stock Price
Gland Pharma Price
Revenue has compounded at 17.7% per year over the past 9 years to 64.31 B INR. Earnings per share have grown at 10.6% per year over the last 9 years. Gland Pharma's net margin stands at 16.0%, down from 27.5% several years earlier. Gland Pharma currently offers a dividend yield of about 0.55%. The payout ratio is around 43% of earnings. Analysts set a median price target of 2,091.00 INR, implying 36.7% below the current price. Of 23 analysts, 16 rate the stock a buy — an overall Buy consensus.
Gland Pharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Gland Pharma business model & stock analysis
Frequently asked questions about Gland Pharma
Analysts currently set an average price target of 2,049.11 INR for the Gland Pharma stock (median: 2,091.00 INR), implying -38.0 % versus the latest price. The consensus is based on 23 analyst ratings.
23 analysts currently rate the Gland Pharma stock: 16 recommend buying, 3 holding and 4 selling.
Converted at the current exchange rate, the Gland Pharma share trades at 31.43 EUR (3,302.40 INR).
The Gland Pharma share (GLAND.NS) is listed on 2 stock exchanges, including: NSE (Indien) (GLAND.NS).
The revenue of Gland Pharma is 64.31 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Gland Pharma is 10.27 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Gland Pharma is currently 53.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Gland Pharma stock.
The price-to-sales ratio (P/S) of Gland Pharma is currently 8.47. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Gland Pharma stock.
The Eulerpool Quality Score for Gland Pharma is 4/10.
The ISIN of Gland Pharma is INE068V01023. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Gland Pharma is GLAND.NS. The ticker symbol is used to trade Gland Pharma shares on the stock exchange.
Gland Pharma stock
Gland Pharma Peer Group
Gland Pharma Ticker
Gland Pharma FIGI
All fundamentals and in-depth analysis of Gland Pharma
Our stock analysis for Gland Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gland Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.